OKLAHOMA CITY, April 09, 2018 -- Federman & Sherwood announces that on April 6, 2018, a class action lawsuit was filed in the United States District Court for the Central District of California against Colony NorthStar, Inc. (NYSE:CLNS). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is February 28, 2017 through March 1, 2018.
Plaintiff seeks to recover damages on behalf of all Colony NorthStar, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Tuesday, June 5, 2018 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
Robin Hester
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: [email protected]
Or, visit the firm’s website at www.federmanlaw.com


Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Capital One Says AML Review Led to Closure of Trump Organization Accounts
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 



